Ratings MetLife, Inc. Nyse

Equities

MET.PRA

US59156R5046

Market Closed - Nyse Other stock markets 01:30:02 18/05/2024 am IST			5-day change	1st Jan Change
24.84 ^USD	-0.12%		+1.59%	+7.77%

10/05	Jones Lang LaSalle Arranges $735 Million Term Loan to Refinance Swan and Dolphin Resort	MT
10/05	Wells Fargo Adjusts Price Target on MetLife to $85 From $86, Keeps Overweight Rating	MT

Strengths

The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company has a low valuation given the cash flows generated by its activity.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
One of the major weak points of the company is its financial situation.

Ratings chart - Surperformance

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
METLIFE, INC.	+7.77%	52.25B	-
AXA	+14.24%	80.23B	B-
AFLAC INCORPORATED	+7.12%	49.51B	B
MANULIFE FINANCIAL CORPORATION	+24.11%	47.43B	B+
PRUDENTIAL FINANCIAL, INC.	+16.97%	43.06B	B+
GENERALI	+30.23%	41.91B	B
SUN LIFE FINANCIAL INC.	+2.40%	29.93B	B
GREAT-WEST LIFECO INC.	-2.49%	29.2B	B-
PRUDENTIAL PLC	-7.66%	28.73B	A-
CATHAY FINANCIAL HOLDING CO., LTD.	+23.28%	25.73B	A

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes